1Okamoto A, Demetrik DJ, Spillare EA. Mutations and altered expression of p16INK4 in human cancer[J]. Proc Natl Acad Sci USA,1994,91:11045-11049.
2Okamoto A, Hussain SP, Hagiwara K. Mutations in the P16 INK4/MTS1/CDKN2, P15 INK4B/MTS2 and P18 genes in primary and metastatic lung cancer[J]. Cancer Res,1995,55:1448-1451.
3HE Xiusheng,SU Qi,CHEN Zhuchu,et al.Expression,mutationand deletion of p16 gene in gastric carcinoma[J].World Journal of Gastroenterology,2001,7:515-519.
4Lu X, Toki T. Expression of p21 in adenocarcinoma of the uterine cervix, a possible immunohistochemical marker of a favorable prognosis[J]. Cancer,1998,82:2409-2417.
5Sasaki T,Takai Y.The Rho small G protein family-Rho.GDI system asatemporal and spatial determinant for cytoskeletal control[J]. Biochem Biophys Res Comm,1998,245(3):641-645.
6Antonarakis S E,Van Aelst L. Mind the GAP, Rho, Rab and GDI[J]. Nature Genet,1998,19:106-108.
7Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins[J]. Physiol Rev, 2001, 81:153-208.
8Chardin P, Boquet P, Madaule P. The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells[J]. EMBO J, 1989,8:1087-1092.
9Olson MF, Ashworth A, Hall A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1[J]. Science, 1995,269:1270-1272.
10Wang TH, Wang HS, Soong YK. Regulation and functions of c-Jun N-terminal kinase/stress-activated protein kinase[J]. Changgeng Yi Xue Za Zhi, 2003,23:57-72.
